Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

Peer Review reports

Original Submission
19 Apr 2019	Submitted	Original manuscript
29 May 2019	Author responded	Author comments - Li Shen Loo
Resubmission - Version 2
29 May 2019	Submitted	Manuscript version 2
1 Jul 2019	Reviewed	Reviewer Report - Maria Pia Prudenzano
9 Jul 2019	Reviewed	Reviewer Report - Franco Granella
19 Jul 2019	Author responded	Author comments - Li Shen Loo
Resubmission - Version 3
19 Jul 2019	Submitted	Manuscript version 3
29 Jul 2019	Author responded	Author comments - Li Shen Loo
Resubmission - Version 4
29 Jul 2019	Submitted	Manuscript version 4
Publishing
30 Jul 2019	Editorially accepted
13 Aug 2019	Article published	10.1186/s12883-019-1420-5

Back to article page